Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Damo Consulting’s Healthcare Digital Transformation Advisory Earns High Marks in Client Experience and Overall Customer Satisfaction in KLAS First Look Report

[ad_1]

Damo Consulting, a leading healthcare digital transformation advisory services firm, announced today what clients think of their experience with Damo when they engaged in a digital transformation project, as reported in the KLAS First Look report.

KLAS helps healthcare providers make informed technology decisions by offering accurate, honest, and impartial vendor performance information.

Client Experience: Initial Look

Clients find Damo Consulting to be highly engaged and focused, resulting in strong perceptions of the firm’s ability to execute and meet expectations. Executive involvement is also rated very high. Many appreciate Damo Consulting’s specialty approach to digital transformation and say the firm doesn’t try to oversell.

KLAS interviewed individuals from large academic health systems and found:

· 100% of the clients will buy Damo’s digital transformation advisory services again

· 100% of clients use Damo for customer experience improvement

· Clients fully appreciate Damo’s robust executive involvement and structured approach to project management

“I wanted Damo Consulting to help me define the important factors of our customer experience. I was interested in digital capabilities across the industry, what everyone else was doing, and the value of certain approaches, and those things were what was delivered. The engagement was well defined, and Damo Consulting delivered. The firm helped validate some things we were already doing and helped the rest of the road map take shape,” says one of the survey respondents, a Chief Digital Officer (CDO).

Nimble, Attentive, and Customer-focused Organization

Damo Consulting is a uniquely positioned digital transformation advisory firm with deep healthcare provider knowledge. Damo’s extensive thought leadership and marketplace have helped the firm gain recognition as a specialized firm in digital transformation advisement. Damo’s DigiMTM digital maturity framework and assessment tool are unique assets that create value through a structured approach to digital maturity benchmarking and an informed approach to investment decisions that accelerate transformation.

“We are delighted to be featured by KLAS in their latest report. Our work with leading healthcare enterprises and our unique frameworks and assets, including a digital maturity model and a market intelligence platform, are being recognized as valuable tools for driving digital transformation,” says Paddy Padmanabhan, CEO of Damo Consulting.

Damo Consulting DigiMTM Digital Maturity Model

The DigiMTM maturity model has emerged as a unique framework and tool for health systems to establish a baseline for digital transformation efforts and develop specific in-market strategies for prioritizing digital health investments.

“Damo Consulting provides a well-designed digital transformation model that is used to assess organizational status for digital capabilities. Model assessments allow the firm to establish effective road maps, digital strategies, and governance frameworks. Damo Consulting’s experience results in well-designed and planned digital processes and workflows,” says KLAS Research Analyst Mike Davis.

Download the complimentary copy of the KLAS Research First Look report here.

About Damo Consulting

Damo Consulting provides digital transformation advisory services to enable healthcare organizations navigate the technology-enabled transition to telehealth and virtual care. We bring deep industry knowledge, market insights and technology skills to help develop and implement enterprise digital roadmaps. We work with healthcare IT and digital health firms to develop and execute market growth strategies. To learn more, visit https://www.damoconsulting.net/.

For media enquiries, write to tess@tesswoodspr.com

Share article on social media or email:

[ad_2]

111MedCo’s 10% Benzoyl Peroxide Acne Bar Chosen as Best Soap Bar for Acne-Prone Skin by Byrdie.com

[ad_1]

111MedCo 10% Maximum Strength Benzoyl Peroxide Acne Treatment Bar For Face and Body

The 111MedCo 10% Benzoyl Peroxide Acne Treatment Bar for face and body was chosen as Best Soap Bar for Acne-Prone Skin by Byrdie.com. The article was titled “These Are The 12 Best Bar Soaps for Men” and was independently researched, tested, reviewed, and recommend.

The article stated: “If you’re prone to breakouts on your body, then this benzoyl-powered bar helps to unclog pores from deep within the skin to neutralize and prevent further episodes. It is also formulated without any fragrance or dyes to remain sensitive while maintaining a pH balance of 6-6.5 (which means it won’t dry your skin since this is a generally safe range for cleansing agents).”

Benzoyl peroxide is a mainstay of any acne treatment regimen around the world, it has been extensively studied, written about and has been in use since 1960. It offers antibacterial effects (kills bacteria), keratolytic effects (helping to loosen outer layers of the skin and shed them), and comedolytic activity (reduces the formation of pimples).

The 111MedCo 10% Benzoyl Peroxide Acne Treatment Bar is a simple and inexpensive way to help treat acne on the face and body.

Bar soaps are making a resurgence due to their simplicity of packaging, only requiring paper and no plastic. They are also lighter to transport than liquid soaps helping to reduce environmental impacts.

All questions should be directed to info@111MedCo.com

Share article on social media or email:

[ad_2]

Innophos Releases New Chelamax® Video Detailing Benefits of Chelated Minerals

[ad_1]

Chelamax® Chelated Minerals

“With the skyrocketing demand for mineral supplements during the last two years, it is critical to understand the quality of the minerals you are buying and how they can impact bioaccessibility and mineral absorption.”

Innophos, a leading international producer of high-performance minerals for the dietary supplement industry, announced the release of its new video demonstrating the significant advantages of Chelamax® Chelated Minerals.

The video expands upon the foundational work presented in Innophos’ recent Chelamax® whitepapers and is narrated by Dr. Robert Finn, Ph.D., Nutrition R&D Director at Innophos. “With the skyrocketing demand for mineral supplements during the last two years, it is critical to understand the quality of the minerals you are buying and how they can impact bioaccessibility and mineral absorption,” says Dr. Finn. “This exciting research allows Innophos to scientifically confirm the quality and full chelation of minerals and to measure the benefits of chelated vs. non chelated minerals.”

In the Chelamax® video, Innophos presents scientific data proving the benefits of chelation in an easy-to-understand format that covers:


  • What chelation is and why it matters
  • Innophos’ industry-leading three-step process to prove chelation
  • Explanation of how minerals are absorbed in the digestive system
  • Results from most recent study showcasing the superior absorption of Chelamax® zinc glycinate vs. zinc oxide

“Only by using these three testing methods together can a product’s true makeup be confirmed—which is why our process is the most comprehensive and accurate—setting a new benchmark in the minerals industry,” says Dr. Finn.

Innophos is committed to providing the highest quality, science-backed products, and has raised the bar in the chelated minerals industry in terms of validation and transparency. Their portfolio of essential ingredients provides the efficacy, purity, and superior performance that today’s educated consumers now expect from the dietary supplements they purchase.

Click here to view the video and learn more about how Chelamax® fully chelated minerals can help you get the most from your mineral supplements.

About Innophos

Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition and industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphate, mineral, enzyme and botanical based ingredients to help our customers offer products that are tasty, healthy, nutritious and economical. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico and China. For more information, please visit http://www.innophos.com.

Share article on social media or email:

[ad_2]

High Multiplex Proteomics Using a Proximity Extension Assay with an Automated Liquid Handling System, Upcoming Webinar Hosted by Xtalks

[ad_1]

With high pipetting accuracy and precision, this liquid handler provides a robust and highly precise automation solution.

Large-scale analysis of proteins is an integral part of the multi-omics approach in understanding human biology and identifying therapeutic targets. However, the full potential of proteomics has not been realized due to common limitations in technologies, including high sample consumption, low specificity, high inter- and intra-assay variations and narrow dynamic range. Here, the featured speakers discuss the combined benefits of a proximity extension assay with an automated liquid handling system.

The Olink proximity extension assay (PEA) technology combines the sensitivity of a polymerase chain reaction (PCR)-based method with the specificity of an antibody-based detection method and the scalability of next-generation sequencing (NGS). This provides a unique solution enabling simultaneous screening of thousands of proteins, using only a few microliters per sample. The PEA technology has a dynamic range of 10 orders of magnitude and requires no sample fractionation. Therefore, the Olink® Explore is an ideal platform for analyzing the proteomes of various sample types.

Eppendorf has partnered with Olink to automate the Olink® Explore workflow on the Eppendorf epMotion® 5075 liquid handler, enabling a simplified setup for a high-throughput screening assay. This is a flexible and user-friendly automated liquid handling platform that significantly reduces assay variation, improves data reproducibility and decreases hands-on time. With high pipetting accuracy and precision, this liquid handler provides a robust and highly precise automation solution.

Join this webinar to learn how the PEA technology automated on a liquid handling system can optimize and advance proteomics studies.

Join Kanhav Khanna, Field Application Specialist, Eppendorf; and Daniel Frederick, Senior Field Application Scientist, Olink, for the live webinar on Tuesday, May 10, 2022, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit High Multiplex Proteomics Using a Proximity Extension Assay with an Automated Liquid Handling System.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

[ad_2]

Critical Elements of Conducting Early Phase Clinical Trials in the US for APAC Sponsors, Upcoming Webinar Hosted by Xtalks

[ad_1]

This webinar will address critical areas to consider when planning for the successful development and initiation of an early phase study in the US: regulatory, medical, operational and cultural.

There is increasing interest in the Asia-Pacific (APAC) biotech industry in initiating early phase clinical trials in the US. This webinar will address critical areas to consider when planning for the successful development and initiation of an early phase study in the US: regulatory, medical, operational and cultural.

In terms of the regulatory piece, the featured speakers will discuss the Investigational New Drug (IND) Application process, including requirements and timelines. In addition, incorporation of non-US data as well as the potential to bridge studies and arms will be explored. Other key considerations include intellectual property (IP) export/import, shipping and customs, differences between medical and standard of care practices, study operations and site differences and overall regulatory timeline differences.

Because of the various differences in initiating and conducting early phase clinical trials between the APAC and US, it is important for the APAC sponsor to find the best CRO partner — one that is experienced in navigating the US clinical trials landscape, has proven expertise to support regulatory activities and understands cultural differences.

Join this webinar to gain insight into the key elements for APAC sponsors to consider when conducting early phase clinical trials in the US.

Join Victoria Allgood, PhD, Vice-President, Scientific Affairs, Oncology, Atlantic Research Group (ARG); Jane Fang, MD, MS, CEO & Founder of Polaris Strategic Partners, Inc.; and Frank Li, MD, PhD, RAC, Founder of BLA Regulatory, LLC, for the live webinar on Thursday, May 12, 2022, at 8am CST (China).

For more information, or to register for this event, visit Critical Elements of Conducting Early Phase Clinical Trials in the US for APAC Sponsors.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

[ad_2]

Sense Relief Launches Version 2.0 of Anti-Nausea Smartwatch App with Improved User Experience and Digital Health Research Capabilities

[ad_1]

“We are excited to grow our user base and see what valuable insights come from this unique and powerful dataset,” says Matt Bucklin, Sense Relief co-founder and CEO.

Sense Relief, Inc. announces the launch of a major update to its anti-nausea smartwatch app on the Apple App Store. The updated Sense Relief app makes it easier for users to activate the app from their iPhone or Apple Watch and track symptoms and usage. Version 2.0 integrates Cardinal Kit for remote clinical studies and advanced data analytics capabilities. The update also includes new branding, enhanced data collection, and improved privacy and security functions. The app remains free to download from the Apple App Store and use and will work on the Apple Watch Model 3 and newer.

Sense Relief is a digital therapeutics company that uses the Apple Watch to deliver acupressure therapy to a user’s wrist to relieve symptoms of nausea and vomiting. The company has plans to expand to additional smartwatches and therapeutic areas. Sense Relief was founded out of a need to manage debilitating pregnancy related nausea and vomiting, or morning sickness, and has now been used over 35,000 times to help ease nausea from motion sickness, migraine-related nausea, VR sickness, nausea from hangovers, and more. The onset of nausea often has no warning, and most anti-nausea medications have a delayed effect and possible unwanted side effects, at least drowsiness. Acupressure has been clinically shown to help relieve nausea in a majority of patients in 16 randomized studies.

In June 2021, Sense Relief received a non-dilutive grant from UCSF/Stanford BioDesign, which supported the development, validation, and integration of Cardinal Kit into Sense Relief’s iPhone App and database. The improved data collection and analysis allow Sense Relief to optimize the user experience, enhance research capabilities, and conduct remote clinical studies. The research areas of most interest are in maternal health, such as predicting and preventing preterm birth. However, researchers are also interested in predicting and interrupting the onset of migraine attacks. “We are excited to grow our user base and see what valuable insights come from this unique and powerful dataset,” says Matt Bucklin, Sense Relief co-founder and CEO.

Cardinal Kit is an open-sourced software for distributed clinical studies developed at Stanford. Cardinal Kit collects over 140 data points from Apple Health and the Apple Watch with the user’s permission. Development of Sense Relief was done by the programming team at Alternova, a software development company specializing in programming for the digital health industry, and overseen by co-founders Ricardo Velasquez and Maria Clara Mesa. Version 2.0 of Sense Relief asks users a series of onboarding questions to categorize the symptoms and causes, followed up with tracking capabilities and questionnaires to get users’ feedback after Sense Relief delivers the therapy to help optimize and customize each user’s treatment.

About Sense Relief

Sense Relief is an antiemetic digital therapeutics company based in San Francisco, California. The Sense Relief app is currently available for free download to the Apple Watch.

Share article on social media or email:

[ad_2]

Zesty Paws & Solid Gold Partner With Greater Good Charities’ Animal Welfare Relief Efforts in Ukraine

[ad_1]

“Just as Greater Good Charities aims to protect the well-being of people, pets, and the planet, the same is true of the brands of H&H Group, where our passion for the wellbeing of people and their pets sits at the heart of everything we do,” said Steve Ball, CEO of North America at H&H Group.

Zesty Paws®, the leading multi-condition pet supplement brand, and Solid Gold®, a natural and holistic pet food brand, both owned by the H&H Group’s Pet Nutrition & Care (PNC) division, have made a combined donation of $20,000 to support Greater Good Charities, 501(c)(3) organization that works to improve the health and well-being of people, pets, and the planet. The donation provides the charitable organization with cash assistance to support humanitarian and animal welfare partners on the ground who are supplying much-needed pet food, veterinary care, and other essential items to those impacted by the crisis in Ukraine.

Zesty Paws and Greater Good Charities successfully partnered before during the COVID-19 crisis to ensure that pets in shelters were getting the care they needed, while waiting for their foster and forever homes. Now, as the public charity focuses its efforts on helping more than four million Ukrainians, pet industry leaders from around the nation, including Zesty Paws and Solid Gold, have come together to support the animal welfare organizations and pet parents.

“Just as Greater Good Charities aim to protect the well-being of people, pets, and the planet, the same is true of the brands of H&H Group, where our passion for the wellbeing of people and their pets sits at the heart of everything we do,” said Steve Ball, CEO of North America at H&H Group. “We’re once again pleased to partner with Greater Good Charities as they mobilize to help the families and pets in need overseas.”

To learn more about Zesty Paws and Solid Gold’s charitable initiatives with Greater Good Charities, or to help the pets and people of Ukraine, please visit greatergood.org.

About Zesty Paws®

At Zesty Paws®, our passion is simple: to enable and inspire a ZEST FOR LIFE in pets and parents. We strive to be the most innovative and trusted brand in functional supplements to guide and empower pets on their journey. We use unique formulas based on active ingredients you know and trust, and that are proven to provide tangible benefits to your pet. We have received thousands of 5-star reviews on channels such as Amazon and Chewy. Pet parents are delighted by our commitment to innovative, high-quality products, as well as by our unparalleled customer service. For information about Zesty Paws, visit ZestyPaws.com or find us on Instagram, Facebook, Twitter (@zestypaws), or LinkedIn.

About Solid Gold Pet

Since 1974, Solid Gold® has been a proven pioneer in craveable holistic nourishment, harnessed in the gut, to help pet families thrive. With over 40 years of nutritional expertise for dogs and cats, we know that pet wellness isn’t just about what you feed your pet. It’s also what they get out of it. That’s why our range of premium kibble, wet food, supplements, and toppers provide mouthwatering, benefit-driven ingredients that nourish that help nourish your pets inside and out. For information about Solid Gold, visit Solidgoldpet.com or find us on Instagram (@solidgoldpets), LinkedIn, or Facebook (@SolidGoldPet).

About H&H Group:

H&H Group is a global health and nutrition company. Dynamic, courageous, and ambitious in its mission to make people healthier and happier, the Group strives to inspire wellness while contributing positively to the needs of society and the planet. The Group has three business segments – Baby, Adult, and Pet Nutrition and Care – supporting whole-family health and happiness, with premium brands providing nutrition and wellness solutions backed by science. Consumer brands include Biostime, Swisse, Zesty Paws, Solid Gold Pet, Dodie, Good Goût, Aurelia London and CBII. The Group is headquartered in Hong Kong SAR and listed on the Hong Kong Stock Exchange, with a second head office in London. More than 3,300 team members are located across 15 countries.

About Greater Good Charities

Greater Good Charities is a 501(c)(3) national nonprofit organization that works to help people, pets, and the planet by mobilizing in response to need and amplifying the good. Greater Good Charities, with a 100/100 rating on Charity Navigator, has provided more than $400 million in impact, including cash grants, in-kind supplies, and programmatic support, to over 5,000 charitable partners in 121 countries since 2007. To learn more about how Greater Good Charities is amplifying the good across the globe, please visit greatergood.org or follow Facebook, Instagram, Twitter, YouTube and TikTok.

Share article on social media or email:



[ad_2]

Human Performance and Rehabilitation Centers, Inc. Announces Partnership with Therapeutic Solutions, Inc.

[ad_1]

News Image

Joining the HPRC family will allow Therapeutic Solutions to grow and provide our new and current patients with even more options for treating existing problems and prevention and wellness options for those who want to improve their game. — Angelo Rizzo, Therapeutic Solutions Clinic Director

Human Performance and Rehabilitation Centers, Inc. (HPRC), a part of the Confluent Health family and therapist-owned practice of 67 years, is proud to announce its newest partnership with Therapeutic Solutions, Inc., a private, therapist-owned physical therapy practice that has led oncology rehab and lymphedema management in the state of Georgia for 25 years.

“Helping our patients to help themselves has always been the core philosophy of Therapeutic Solutions,” said Clinic Director Angelo Rizzo, PT, DPT, CLT. “Our team has consistently proven that state-of-the-art physical therapy practices combined with a relaxing outpatient environment can assist in returning to normal functional activity. Joining the HPRC family will allow Therapeutic Solutions to grow and provide our new and current patients with even more options for treating existing problems and prevention and wellness options for those who want to improve their game.”

While patients will continue to see familiar faces at Therapeutic Solutions and be provided with the same services, the clinical team will gain access to the shared management services provided by HPRC’s parent company, Confluent Health. These services include efficient branding, marketing, and finance tools as well as continuing education programs and staff development opportunities such as Evidence in Motion, a nationally recognized physical therapy education program.

“We are proud to partner with Therapeutic Solutions and have known about their focus on prevention and treatment within the physical therapy community for years,” said HPRC’s CEO Brian McCluskey, Ph.D. “As a physical therapist-owned business, Therapeutic Solutions has mastered the integration of bringing together the best clinical talent in the Conyers area and delivering the highest quality care in the community,” continued McCluskey. “In the years to come, accommodating the vast growth and volume of musculoskeletal and chronic pain patients will require proven, hands-on partnerships and we believe Therapeutic Solutions is more than equipped to meet, and even exceed, this need.”

“We are proud to partner with HPRC and are excited to welcome Therapeutic Solutions to the Confluent family,” says Confluent Health’s President and CEO Larry Benz, PT, DPT, OCS, MBA, MAPP. “Brian’s entire team are pre-eminent clinical leaders and bringing in Therapeutic Solutions is going to add significant value as we grow together. Our partnership has endless possibilities.”

This partnership makes 13 HPRC clinics across the southeastern United States.

For more information about HPRC please visit https://hprc.net. For more information about Therapeutic Solutions, or to meet with one of their expert therapists, please visit https://therapeuticsolutions.com/.

About Human Performance and Rehabilitation Centers, Inc.:

HPRC is a Georgia, Alabama and South Carolina-based, private physical therapy practice group. As a proud member of the Confluent Health family, HPRC positively impacts patients’ lives by delivering the best care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family. For more information, visit hprc.net, or find them on Facebook at @hprctherapy.

Share article on social media or email:

[ad_2]

University of Camerino Signs Strategic Partnership with CureLab Veterinary to Revolutionize Cancer Treatment for Companion Animals

[ad_1]

CureLab Veterinary Inc. is a biotech company devoted to help pets live longer, healthier, and happier lives.

The new clinical data released by CureLab Oncology paves the road to even more new discoveries in our laboratory, while at the same time, our lab data helps CureLab target new applications for its p62 product.

The University of Camerino (UniCam) has extended its strategic business partnership with CureLab Oncology Inc., a clinical-stage biotech company, to develop anti-cancer immunotherapy for humans, and has signed a similar agreement with CureLab Veterinary Inc., to reapply this medicine for treatment of companion animals.

In 2012, the university signed a strategic partnership agreement with CureLab Oncology for researching the DNA plasmid coding p62/SQSTM1 gene (p62) that resulted in patents being granted in more than 20 countries. Subsequently, initial p62 plasmid clinical trials have shown great promise in treating the deadliest forms of ovarian and breast cancer. Given this success, CureLab Oncology and UniCam have agreed to extend their partnership.

As a first result of the prolonged partnership agreement, scientists from UniCam and CureLab just published a paper in the journal General and Comparative Endocrinology, one of the top scientific journals focused on animal science and zoology. The choice of a journal was based on a concomitant agreement that UniCam signed with CureLab Veterinary, which licensed the p62 IP for application in cats, dogs, and horses. Earlier, this scientific team successfully treated 10 out of 11 dogs with breast cancer.

“UniCam has a well-established School of Biosciences and Veterinary Medicine,” said Prof. Guido Favia, director of the school. “This new partnership with CureLab Veterinary, based on both scientific and clinical strength, brings attractive development opportunities for the entire school.”

“We are very pleased to continue our partnership with CureLab Oncology,” said Prof. Maria Giovanna Sabbieti of the School of Biosciences and Veterinary Medicine at UniCam. “The new clinical data released by CureLab Oncology paves the road to even more new discoveries in our laboratory, while at the same time, our lab data helps CureLab target new applications for its p62 product.”

“Our partnership with CureLab Veterinary opens up new opportunities for the research on bone and inflammatory-based diseases of domestic and farm animals,” said Dr. Dimitrios Agas of the School of Biosciences and Veterinary Medicine at UniCam.

“CureLab Veterinary is very pleased to be working with the University of Camerino to explore translational studies in the areas of osteoarthritis, cancer, aging, and age-associated diseases to improve and extend the lives of our four-legged family members,” said Robert Devlin, DVM, MBA, of CureLab Veterinary.

About the University of Camerino

The University of Camerino is one of the oldest universities in Europe and was ranked the best university of Italy among those with fewer than 10,000 students, according to the Guida Censis Repubblica 2011 and 2012 ranking.

About CureLab Veterinary

CureLab Veterinary Inc. is a biotech company devoted to help pets live longer, healthier, and happier lives. CureLab Veterinary has an exclusive license for application of CureLab Oncology IP to dogs, cats and horses. To learn more, visit curelabveterinary.com.

About CureLab Oncology

CureLab Oncology Inc. is a clinical-stage immuno-oncology biotech company headquartered in the greater Boston area. CureLab is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. To learn more, visit curelaboncology.com.

Media contact:

Tim Cox, ZingPR, tim@zingpr.com

Share article on social media or email:

[ad_2]

New Communication Article Collection From Supportiv

[ad_1]

Supportiv Communication Collection | Photo by Kate Kalvach on Unsplash

Supportiv Communication Collection | Photo by Kate Kalvach on Unsplash

Communication is most effective if it gets the message across without distressing the recipient, which can put them into a defensive or shut down mode.

When approaching a challenging conversation topic, we need to consider our own emotional needs, the needs of those on the receiving end, the contexts of those needs, and the ways in which we share and receive information about all the factors at play.

Our communication style affects others, so the approach we use truly matters. In its new communication article collection, Supportiv (https://www.supportiv.com) provides step-by-step, how-to guides for reducing anxiety, overcoming awkwardness, confidently conveying your point, and more. Most importantly, these articles highlight how to stay true to oneself while staying conscious of others’ emotional needs in conversation.

Underlining the difficulty of conversing nowadays, Supportiv CEO & Co-Founder Helena Plater-Zyberk notes that “Communication is most effective if it gets the message across without distressing the recipient, which can put them into a defensive or shut down mode. In today’s world, where most of us live on the edge of stress, our conversations are trickier to navigate and become more challenging.”

Supportiv’s communication resources (https://www.supportiv.com/communication) aim to simplify the act of communicating–removing the guesswork, shame, or fear of managing emotions that can come with conversational exchanges. Topics in the collection include:


  • Being An Authentic Email Communicator
  • How To Apologize Effectively
  • I’ve Been Told I’m A Mansplainer. How Do I Stop?
  • Ask For What You Want With These Easy Phrases
  • 15 Things You Can Say To A Friend Who’s Struggling
  • Boost Your Social Skills With 3 DBT Techniques
  • How To Decline An Invitation Without Being A Jerk
  • I Screwed Up: What To Do If You’ve Made A Mistake
  • How Not To Suck At Listening
  • Balance Your Wellbeing With Others’ Expectations
  • How To Respond When Someone Is Overly Self Deprecating
  • Build Assertiveness Skills
  • How To Recommend Therapy To Someone You Care About
  • Learn How To Take A Compliment
  • Does Your Relationship Need A Boundary Contract?

Supportiv Co-Founder Pouria Mojabi adds: “Whether you’re communicating something positive or negative, asking for help or forgiveness, supporting someone else, or just navigating daily social interactions–these new articles hold insights that apply to everyone at one time or another.”

In addition to its peer-to-peer support network, relevant Supportiv articles and tips also surface in real-time inside its 24/7 peer support chats. By typing a few words in response to the question: “What’s your struggle?” users are matched in under a minute to topic-specific peer-to-peer group chats for anonymous support–from feeling hopeless to overwhelmed, from dating struggles to breaking up, and from anhedonia to longing. Even experiences regarding trauma, racism, and discrimination are up for discussion in Supportiv’s anonymous peer support chats.

Find communication tips, guides, and more at https://www.supportiv.com/communication.

Supportiv has already enabled over 1.1 million users to feel less lonely, anxious, stressed, misunderstood, and hopeless through its moderator-guided chats with AI-driven content and resource recommendations. See what real users have to say, here: https://www.supportiv.com/users-testimonials.

Share article on social media or email:

[ad_2]